Ursprung des Netzwerks ersten Grades von Konstantin Zhernosekov
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
ITM Solucin GmbH
ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services ITM Solucin GmbH provides scientific research and development services. The private company is based in Garching, Germany. The CEOs of the German company are Steffen Schuster, Klaus Maleck, Konstantin Zhernosekov.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Konstantin Zhernosekov
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
TVM Capital GmbH
TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Director of Finance/CFO | |
EVOTEC SE | Pharmaceuticals: Major | Director of Finance/CFO | |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Packaged Software | Director/Board Member | |
iTAC Software AG
iTAC Software AG Packaged SoftwareTechnology Services iTAC Software AG provides software solutions. It offers serves the automotive industry, medical technologies, metal processing industry, energy and utilities industry, and electronics industry. The firm's products are manufacturing execution system (MES) suite, embedded systems, smart devices and enterprise framework. The company was founded by Dieter Meuser, Volker Burch and Christine Lahnstein in 1998 and is headquartered in Montabaur, Germany. | Packaged Software | Director/Board Member | |
University of Strasbourg | College/University | Graduate Degree | |
European ScreeningPort GmbH | Chairman | ||
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Biotechnology | Corporate Officer/Principal | |
Max Planck Institut für Pflanzenzüchtungsforschung | College/University | Doctorate Degree | |
Universität Educatis | College/University | Masters Business Admin | |
ITM Isotopen Technologien München AG
ITM Isotopen Technologien München AG Miscellaneous Commercial ServicesCommercial Services ITM Isotopen Technologien München AG develops diagnostic and therapeutic radionuclides and radiopharmaceuticals. Its products include EnolucinBeta, 188w/188re generator, 255AC/213Bi Generator, IQS-TS, IQS, consumables, and GMP Radiolabeling service. The company was founded in 2004 and is headquartered in Garching, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | Pharmaceuticals: Major | Chief Executive Officer | |
ArchiMed SAS
ArchiMed SAS Investment ManagersFinance ArchiMed SAS (ArchiMed) is a private equity firm founded in 2014 by Cedric Berger, David Piccoli, and Vincent Guillaumot. The firm is headquartered in Lyon, France. | Investment Managers | Private Equity Investor |
Statistik
International
Deutschland | 11 |
Frankreich | 3 |
Schweiz | 2 |
Sektoral
Health Technology | 4 |
Technology Services | 4 |
Consumer Services | 4 |
Finance | 3 |
Commercial Services | 2 |
Operativ
Chief Executive Officer | 4 |
Director/Board Member | 3 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Chairman | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Klaus Maleck | 8 |
Steffen Schuster | 7 |
- Börse
- Insiders
- Konstantin Zhernosekov
- Unternehmensverbindungen